Site Sponsors
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
Posted in | Nanobusiness

There is 1 related live offer.

Save 25% on magneTherm

Triplet of Awards in the Offing for Specialist Bio-Nanotechnology Product Development Consultancy

Published on December 4, 2009 at 5:25 PM

Bio Nano Consulting (BNC), the specialist bio-nanotechnology product development consultancy, is delighted to be heading into only their second year of trading with one award already under their belt and two further award shortlistings. In recognition of their internationalisation, significant progress and performance as ambassadors of the UK life science sector, BNC has been shortlisted for the Genesis Awards' UKTI assisted newcomer of the year and Company Newsflow of the Year. Meanwhile, Dr Rachel McKendry, one of BNC's key collaborators, recently received the prestigious Paterson medal and prize from the Institute of Physics, in recognition of her international contributions.

The Genesis Awards celebrate the best that the UK has to offer in biotech and recognise the great success achieved by the UK's leading companies, universities and inward investors over the previous 12 months. Being shortlisted for these awards further enhances BNC's reputation as a commercially-focused consultancy with world class technology and expertise. With their rapidly expanding portfolio of clients in a variety of areas, including biotechnology, defence, electronics, pharmaceutical and med-tech, the future is looking increasingly bright for BNC.

BNC's CEO, Dr David Sarphie commented "It has been a fantastic year for BNC. We have literally gone from strength to strength with many sizable contracts won, a 3 fold increase in turnover and expansion of our staff to 11 from just 3. To have this recognised by these prestigious organisations is a tremendous honour."

The Genesis Awards take place at London's Queen Elizabeth Conference Centre on the 10th December.

The BNC is a specialist research and development consultancy operating in the convergent field of bionanotechnology. A joint venture of Imperial College London and University College London, the BNC is funded through the Technology Strategy Board (TSB) with additional support from the London Development Agency (LDA).

Along with its partner organisation, the National Physical Laboratory, the BNC offers a service to the biomedical and healthcare industries in microsystems and nanotechnology. This encompasses design, 3-D modelling and visualisation, rapid prototyping, and characterisation.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Submit